A CD137 agonist also increased p65 expression and induced p65 nuclear translocation in CD8+ T cells, which suggests a mechanism for enhancing the functions of CD8+ T cells to induce gastric cancer cell apoptosis by a CD137 agonist. Here, TNFRSF9 is linked to gastric cancer.